• 13809 引文
  • 49 h-指數
1987 …2020

每年研究成果

如果您對這些純文本內容做了任何改變,很快就會看到。

研究成果

2020
開啟存取

Electric Field–Induced Release and Measurement (EFIRM): Characterization and Technical Validation of a Novel Liquid Biopsy Platform in Plasma and Saliva

Tu, M., Cheng, J., Chen, Y. L., Jea, W. C., Chen, W. L., Chen, C. J., Ho, C. L., Huang, W. L., Lin, C. C., Su, W. C., Ye, Q., Deignan, J., Grody, W., Li, F., Chia, D., Wei, F., Liao, W., Wong, D. T. W. & Strom, C. M., 2020 八月, 於 : Journal of Molecular Diagnostics. 22, 8, p. 1050-1062 13 p.

研究成果: Article

1 引文 斯高帕斯(Scopus)

Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC

Nishio, M., Felip, E., Orlov, S., Park, K., Yu, C. J., Tsai, C. M., Cobo, M., McKeage, M., Su, W. C., Mok, T., Scagliotti, G. V., Spigel, D. R., Viraswami-Appanna, K., Chen, Z., Passos, V. Q. & Shaw, A. T., 2020 四月, 於 : Journal of Thoracic Oncology. 15, 4, p. 609-617 9 p.

研究成果: Article

開啟存取
2 引文 斯高帕斯(Scopus)

Impact of cooking oil fume exposure and fume extractor use on lung cancer risk in non-smoking Han Chinese women

Chen, T. Y., Fang, Y. H., Chen, H. L., Chang, C. H., Huang, H., Chen, Y. S., Liao, K. M., Wu, H. Y., Chang, G. C., Tsai, Y. H., Wang, C. L., Chen, Y. M., Huang, M. S., Su, W. C., Yang, P. C., Chen, C. J., Hsiao, C. F. & Hsiung, C. A., 2020 十二月 1, 於 : Scientific reports. 10, 1, 6774.

研究成果: Article

開啟存取

Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1‒Positive, Advanced Non‒Small-Cell Lung Cancer in the KEYNOTE-010 Study

Herbst, R. S., Garon, E. B., Kim, D. W., Cho, B. C., Perez-Gracia, J. L., Han, J. Y., Arvis, C. D., Majem, M., Forster, M. D., Monnet, I., Novello, S., Szalai, Z., Gubens, M. A., Su, W. C., Ceresoli, G. L., Samkari, A., Jensen, E. H., Lubiniecki, G. M. & Baas, P., 2020 五月 10, 於 : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 14, p. 1580-1590 11 p.

研究成果: Article

6 引文 斯高帕斯(Scopus)

Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan

Chen, Y. M., Chih-Hsin Yang, J., Su, W. C., Chong, I. W., Hsia, T. C., Lin, M. C., Chang, G. C., Chiu, C. H., Ho, C. C., Wu, S. Y., Hung, J. Y., Wang, C. C., Yang, T. Y. & Yu, C. J., 2020, (Accepted/In press) 於 : Journal of the Formosan Medical Association.

研究成果: Article

開啟存取

Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

Sequist, L. V., Han, J. Y., Ahn, M. J., Cho, B. C., Yu, H., Kim, S. W., Yang, J. C. H., Lee, J. S., Su, W. C., Kowalski, D., Orlov, S., Cantarini, M., Verheijen, R. B., Mellemgaard, A., Ottesen, L., Frewer, P., Ou, X. & Oxnard, G., 2020 三月, 於 : The Lancet Oncology. 21, 3, p. 373-386 14 p.

研究成果: Article

19 引文 斯高帕斯(Scopus)

Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts

Bang, Y. J., Su, W. C., Schuler, M., Nam, D. H., Lim, W. T., Bauer, T. M., Azaro, A., Poon, R. T. P., Hong, D., Lin, C. C., Akimov, M., Ghebremariam, S., Zhao, S., Giovannini, M. & Ma, B., 2020 二月 1, 於 : Cancer Science. 111, 2, p. 536-547 12 p.

研究成果: Article

開啟存取
3 引文 斯高帕斯(Scopus)

Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model

Chien, L. H., Chen, C. H., Chen, T. Y., Chang, G. C., Tsai, Y. H., Hsiao, C. F., Chen, K. Y., Su, W. C., Wang, W. C., Huang, M. S., Chen, Y. M., Chen, C. Y., Liang, S. K., Chen, C. Y., Wang, C. L., Lee, M. H., Chung, R. H., Tsai, F. Y., Hu, J. W., Katki, H. A. 及其他8, Chatterjee, N., Chanock, S. J., Rothman, N., Lan, Q., Yang, P. C., Chen, C. J., Chang, I. S. & Hsiung, C. A., 2020 二月 1, 於 : Cancer Epidemiology Biomarkers and Prevention. 29, 2, p. 452-459 8 p.

研究成果: Article

開啟存取
1 引文 斯高帕斯(Scopus)

Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women

Wong, J. Y. Y., Zhang, H., Hsiung, C. A., Shiraishi, K., Yu, K., Matsuo, K., Wong, M. P., Hong, Y. C., Wang, J., Seow, W. J., Wang, Z., Song, M., Kim, H. N., Chang, I. S., Chatterjee, N., Hu, W., Wu, C., Mitsudomi, T., Zheng, W., Kim, J. H. 及其他166, Seow, A., Caporaso, N. E., Shin, M. H., Chung, L. P., An, S. J., Wang, P., Yang, Y., Zheng, H., Yatabe, Y., Zhang, X. C., Kim, Y. T., Cai, Q., Yin, Z., Kim, Y. C., Bassig, B. A., Chang, J., Ho, J. C. M., Ji, B. T., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Hosgood, H. D., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S. I., Kubo, M., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Shi, J., Song, L., Hua, X., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wei, F., Matsuda, F., Su, J., Kim, Y. H., Oh, I. J., Song, F., Su, W. C., Chen, Y. M., Chang, G. C., Chen, K. Y., Huang, M. S., Chien, L. H., Xiang, Y. B., Park, J. Y., Kweon, S. S., Chen, C. J., Lee, K. M., Blechter, B., Li, H., Gao, Y. T., Qian, B., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Wang, W. C., Chung, C. C., Burdett, L., Yeager, M., Hutchinson, A., Berndt, S. I., Wu, W., Pang, H., Li, Y., Choi, J. E., Park, K. H., Sung, S. W., Liu, L., Kang, C. H., Zhu, M., Chen, C. H., Yang, T. Y., Xu, J., Guan, P., Tan, W., Wang, C. L., Hsin, M., Sit, K. Y., Ho, J., Chen, Y., Choi, Y. Y., Hung, J. Y., Kim, J. S., Yoon, H. I., Lin, C. C., Park, I. K., Xu, P., Wang, Y., He, Q., Perng, R. P., Chen, C. Y., Vermeulen, R., Wu, J., Lim, W. Y., Chen, K. C., Li, Y. J., Li, J., Chen, H., Yu, C. J., Jin, L., Chen, T. Y., Jiang, S. S., Liu, J., Yamaji, T., Hicks, B., Wyatt, K., Li, S. A., Dai, J., Ma, H., Jin, G., Song, B., Wang, Z., Cheng, S., Li, X., Ren, Y., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Zhu, J., Yang, K., Jiang, G., Fei, K., Wu, G., Lin, H. C., Chen, H. L., Fang, Y. H., Tsai, F. Y., Hsieh, W. S., Yu, J., Stevens, V. L., Laird-Offringa, I. A., Marconett, C. N., Rieswijk, L., Chao, A., Yang, P. C., Shu, X. O., Wu, T., Wu, Y. L., Lin, D., Chen, K., Zhou, B., Huang, Y. C., Kohno, T., Shen, H., Chanock, S. J., Rothman, N. & Lan, Q., 2020 三月, 於 : Genomics. 112, 2, p. 1223-1232 10 p.

研究成果: Article

開啟存取
1 引文 斯高帕斯(Scopus)

Ultra-short circulating tumor dna (UsctDNA) in plasma and saliva of non-small cell lung cancer (NSCLC) patients

Li, F., Wei, F., Huang, W. L., Lin, C. C., Li, L., Shen, M. M., Yan, Q., Liao, W., Chia, D., Tu, M., Tang, J. H., Feng, Z., Kim, Y., Su, W. C. & Wong, D. T. W., 2020 八月, 於 : Cancers. 12, 8, p. 1-15 15 p., 2041.

研究成果: Article

開啟存取
2019

A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

Lin, C. C., Arkenau, H. T., Lu, S., Sachdev, J., de Castro Carpeño, J., Mita, M., Dziadziuszko, R., Su, W. C., Bobilev, D., Hughes, L., Chan, J., Zhang, Z. Y. & Weiss, G. J., 2019 七月 16, 於 : British Journal of Cancer. 121, 2, p. 131-138 8 p.

研究成果: Article

開啟存取
2 引文 斯高帕斯(Scopus)
開啟存取
1 引文 斯高帕斯(Scopus)
開啟存取
2 引文 斯高帕斯(Scopus)

Erratum: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy (Oncotarget (2015) 6 (13671–13687) DOI: 10.18632/oncotarget.3701)

Hsu, T. I., Chen, Y. J., Hung, C. Y., Wang, Y. C., Lin, S. J., Su, W. C., Lai, M. D., Kim, S. Y., Wang, Q., Qian, K., Goto, M., Zhao, Y., Kashiwada, Y., Lee, K. H., Chang, W. C. & Hung, J. J., 2019 一月 1, 於 : Oncotarget. 10, 60, p. 6536-6537 2 p.

研究成果: Comment/debate

開啟存取
1 引文 斯高帕斯(Scopus)

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation

Yang, J. C. H., Gadgeel, S. M., Sequist, L. V. D., Wu, C. L., Papadimitrakopoulou, V. A., Su, W. C., Fiore, J., Saraf, S., Raftopoulos, H. & Patnaik, A., 2019 三月, 於 : Journal of Thoracic Oncology. 14, 3, p. 553-559 7 p.

研究成果: Article

19 引文 斯高帕斯(Scopus)

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Mok, T. S. K., Wu, Y. L., Kudaba, I., Kowalski, D. M., Cho, B. C., Turna, H. Z., Castro, G., Srimuninnimit, V., Laktionov, K. K., Bondarenko, I., Kubota, K., Lubiniecki, G. M., Zhang, J., Kush, D., Lopes, G., Gomez Aubin, G., Fein, L., Kaen, D., Kowalyszyn, R., Lerzo, G. 及其他236, Martinengo, G., Molina, M., Richardet, E., Picon, P., Varela, M., Zarba, J. J., de Azevedo, S. J., Barrios, C. H., Beato, C., Cerny, C. A. S., De Marchi, P. R. M., Fernandes, G., Franke, F. A., Freitas, H., Girotto, G., Lopes, V., Santos, L., Costa, M. A., Shimada, A. K., Smaletz, O., Soares, J. P. H., Victorino, A. P., Ferreira, C., Koleva, M., Koynov, K., Micheva, R., Deliverski, T., Milanova, Z., Doganov, B., Cheng, S., De Angelis, F., Speranza, G., Juergens, R. A., Ksienski, D., Fenton, D., Aren, O., Caglevic, C., Galindo, H., Rey, F., Chang, J., Chen, G., Chen, X., Ouyang, X., Cheng, Y., Ding, Z., Hou, M., Fan, Y., Feng, J., He, J., He, Y., Hu, Y., Li, W., Liu, X., Liu, Z., Lu, S., Qin, S., Tang, Q., Wang, B., Wang, K., Zhang, L., Zhang, X., Zhao, J., Wang, J., Zhou, C., Zhou, J., Zhou, Q., Wu, Y., Cardona, A., Duarte, R., Gomez Wolff, L., Zambrano, A., Vallejo, M., Havel, L., Kolek, V., Kolman, P., Koubkova, L., Petruzelka, L., Popelkova, P., Roubec, J., Vanasek, J., Vlasek, T., Jaal, J., Kuusk, G., Avendano, O., Castro, H., Lopez, K., Sandoval, M., Ho, C. M. J., Lo, S. H., Laczo, I., Piko, B., Ostoros, G., Aoe, K., Fujisaka, Y., Hirashima, T., Horiike, A., Hosomi, Y., Hotta, K., Ichiki, M., Imamura, F., Iwamoto, Y., Kasahara, K., Katakami, N., Kato, T., Murakami, S., Kawaguchi, T., Kishi, K., Kubota, K., Kurata, T., Torii, Y., Nakahara, Y., Nishimura, T., Ohira, T., Saka, H., Sawa, T., Seki, N., Sugawara, S., Takahashi, K., Takigawa, N., Tanaka, H., Yamada, K., Yokoyama, T., Yokoyama, T., Yoshioka, H., Kudaba, I., Purkalne, G., Stara, Z., Cesas, A., Cicenas, S., Zemaitis, M., How, S. H., Liam, C. K., Ong, C. K., Tho, L. M., Arrieta Rodriguez, O., de The Bustamante Valles, F., Hernandez Hernandez, C., Mas, L., Vera, L., Salas, J., Tejada, H., Edusma-Dy, R., Galvez, C., Ladrera, G. E. I., Tan Chun Bing, J., Jassem, J., Kalinka-Warzocha, E., Karaszewska, B., Kazarnowicz, A., Kowalski, D., Lesniewski Kmak, K., Ramlau, R., Araujo, A., Barata, F., Gil, N., Hespanhol, V., Alexandru, A., Dediu, M., Cherciu, N., Ciurescu, D., Ganea, D., Miron, L., Sirbu, D., Turdean, M., Emelyanov, S., Karaseva, N., Kuzina, L., Lazarev, S., Lifirenko, I., Bolotina, L., Lipatov, O., Ovchinnikova, E., Matrosova, M., Alyasova, A., Poltoratsky, A., Taranov, P., Zarubenkov, O., Cohen, G., Dreosti, L., Seolwane, F., Hall, J., Hart, G., Jordaan, C., Buddu, S., Botha, M., Landers, G., Rappaport, B., Ruff, P., Shepherd, L., Szpak, W., Ahn, M. J., Cho, B. C., Kim, J. H., Bergstrom, P., Ohman, R., Griph, H., Betticher, D., Ochsenbein, A., Zippelius, A., Chan, G. C., Chiu, C. H., Hsia, T. C., Su, W. C., Yang, C. H., Ativitavas, T., Danchaivijitr, P., Srimuninnimit, V., Seetalarom, K., Sookprasert, A., Sriuranpong, V., Altundag, O., Cay Senler, F., Erman, M., Goksel, T., Goker, E., Ozyilkan, O., Seker, M., Gumus, M., Turna, H., Yumuk, F., Adamchuk, G., Bondarenko, I., Ivashchuk, O., Ponomarova, O., Rusyn, A., Shevnya, S., Shparyk, Y., Sinielnikov, I., Andrusenko, O., Trukhyn, D., Ursol, G., Vynnychenko, I., Nguyen, T. Q., Pham, X. D., Castro, G. & Kubota, K., 2019 五月 4, 於 : The Lancet. 393, 10183, p. 1819-1830 12 p.

研究成果: Article

341 引文 斯高帕斯(Scopus)
開啟存取
24 引文 斯高帕斯(Scopus)

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Nakagawa, K., Garon, E. B., Seto, T., Nishio, M., Ponce Aix, S., Paz-Ares, L., Chiu, C. H., Park, K., Novello, S., Nadal, E., Imamura, F., Yoh, K., Shih, J. Y., Au, K. H., Moro-Sibilot, D., Enatsu, S., Zimmermann, A., Frimodt-Moller, B., Visseren-Grul, C., Reck, M. 及其他96, Chu, Q., Cortot, A., Pujol, J. L., Fabre, E., Lamour, C., Bischoff, H., Kollmeier, J., Kimmich, M., Engel-Riedel, W., Hammerschmidt, S., Schütte, W., Syrigos, K., Ho, J. C. M., Au, K. H., Ardizzoni, A., Pasello, G., Gregorc, V., Del Conte, A., Galetta, D., Takahashi, T., Kumagai, T., Hotta, K., Goto, Y., Hosomi, Y., Sakai, H., Takiguchi, Y., Kim, Y. H., Kurata, T., Yamaguchi, H., Daga, H., Okamoto, I., Satouchi, M., Ikeda, S., Kasahara, K., Atagi, S., Azuma, K., Aoe, K., Horio, Y., Yamamoto, N., Tanaka, H., Watanabe, S., Nogami, N., Ozaki, T., Koyama, R., Hirashima, T., Kaneda, H., Tomii, K., Fujita, Y., Seike, M., Nishimura, N., Kato, T., Ichiki, M., Saka, H., Hirano, K., Nakahara, Y., Sugawara, S., Kim, S. W., Min, Y. J., Lee, H. W., Kang, J. H., An, H. J., Lee, K. H., Kim, J. S., Lee, G. W., Lee, S. Y., Alexandru, A., Udrea, A. A., Juan-Vidal, Ó., Nadal-Alforja, E., Gil-Bazo, I., Ponce-Aix, S., Rubio-Viqueira, B., Alonso Garcia, M., Felip Font, E., Fuentes Pradera, J., Coves Sarto, J., Lin, M. C., Su, W. C., Hsia, T. C., Chang, G. C., Wei, Y. F., Su, J., Cicin, I., Goksel, T., Harputluoglu, H., Ozyilkan, O., Henning, I., Popat, S., Hatcher, O., Mileham, K., Acoba, J., Garon, E., Jung, G., Raj, M., Martin, W. & Dakhil, S., 2019 十二月, 於 : The Lancet Oncology. 20, 12, p. 1655-1669 15 p.

研究成果: Article

31 引文 斯高帕斯(Scopus)
開啟存取
1 引文 斯高帕斯(Scopus)

Tissue and plasma EGFR mutation analysis in the FLAURA trial: Osimertinib versus Comparator EGFR tyrosine kinase inhibitor as first-line treatment in patients with EGFR-mutated advanced non–small cell lung cancer

Gray, J. E., Okamoto, I., Sriuranpong, V., Vansteenkiste, J., Imamura, F., Lee, J. S., Pang, Y. K., Cobo, M., Kasahara, K., Cheng, Y., Nogami, N., Cho, E. K., Su, W. C., Zhang, G., Huang, X., Li-Sucholeiki, X., Lentrichia, B., Dearden, S., Jenkins, S., Saggese, M. 及其他2, Rukazenkov, Y. & Ramalingam, S. S., 2019 十一月 15, 於 : Clinical Cancer Research. 25, 22, p. 6644-6652 9 p.

研究成果: Article

8 引文 斯高帕斯(Scopus)
2018
開啟存取
1 引文 斯高帕斯(Scopus)
6 引文 斯高帕斯(Scopus)
159 引文 斯高帕斯(Scopus)
7 引文 斯高帕斯(Scopus)

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

John, T., Akamatsu, H., Delmonte, A., Su, W. C., Lee, J. S., Chang, G. C., Huang, X., Jenkins, S. & Wu, Y. L., 2018 十二月, 於 : Lung Cancer. 126, p. 133-138 6 p.

研究成果: Article

7 引文 斯高帕斯(Scopus)

Electric Field–Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment

Wei, F., Strom, C. M., Cheng, J., Lin, C. C., Hsu, C. Y., Soo Hoo, G. W., Chia, D., Kim, Y., Li, F., Elashoff, D., Grognan, T., Tu, M., Liao, W., Xian, R., Grody, W. W., Su, W. C. & Wong, D. T. W., 2018 十一月, 於 : Journal of Molecular Diagnostics. 20, 6, p. 738-742 5 p.

研究成果: Article

8 引文 斯高帕斯(Scopus)

Osimertinib in untreated EGFR-Mutated advanced non-small-cell lung cancer

Soria, J. C., Ohe, Y., Vansteenkiste, J., Reungwetwattana, T., Chewaskulyong, B., Lee, K. H., Dechaphunkul, A., Imamura, F., Nogami, N., Kurata, T., Okamoto, I., Zhou, C., Cho, B. C., Cheng, Y., Cho, E. K., Voon, P. J., Planchard, D., Su, W. C., Gray, J. E., Lee, S. M. 及其他4, Hodge, R., Marotti, M., Rukazenkov, Y. & Ramalingam, S. S., 2018 一月 11, 於 : New England Journal of Medicine. 378, 2, p. 113-125 13 p.

研究成果: Article

1000 引文 斯高帕斯(Scopus)

Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib after Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients with EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer

Wu, Y. L., Zhang, L., Kim, D. W., Liu, X., Lee, D. H., Yang, J. C. H., Ahn, M. J., Vansteenkiste, J. F., Su, W. C., Felip, E., Chia, V., Glaser, S., Pultar, P., Zhao, S., Peng, B., Akimov, M. & Tan, D. S. W., 2018 十一月 1, 於 : Journal of Clinical Oncology. 36, 31, p. 3101-3109 9 p.

研究成果: Article

63 引文 斯高帕斯(Scopus)
6 引文 斯高帕斯(Scopus)

Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer

Gerber, D. E., Horn, L., Boyer, M., Sanborn, R., Natale, R., Palmero, R., Bidoli, P., Bondarenko, I., Germonpre, P., Ghizdavescu, D., Kotsakis, A., Lena, H., Losonczy, G., Park, K., Su, W. C., Tang, M., Lai, J., Kallinteris, N. L., Shan, J. S., Reck, M. 及其他1, Spigel, D. R., 2018 七月 1, 於 : Annals of Oncology. 29, 7, p. 1548-1553 6 p.

研究成果: Article

9 引文 斯高帕斯(Scopus)
10 引文 斯高帕斯(Scopus)
2017

Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study

Ahn, M. J., Kim, D. W., Cho, B. C., Kim, S. W., Lee, J. S., Ahn, J. S., Kim, T. M., Lin, C. C., Kim, H. R., John, T., Kao, S., Goldman, J. W., Su, W. C., Natale, R., Rabbie, S., Harrop, B., Overend, P., Yang, Z. & Yang, J. C. H., 2017 十一月, 於 : The Lancet Respiratory Medicine. 5, 11, p. 891-902 12 p.

研究成果: Article

38 引文 斯高帕斯(Scopus)

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations

Seow, W. J., Matsuo, K., Hsiung, C. A., Shiraishi, K., Song, M., NamKim, H., Wong, M. P., Hong, Y. C., Dean Hosgood, H., Wang, Z., Chang, I. S., Wang, J. C., Chatterjee, N., Tucker, M., Wei, H., Mitsudomi, T., Zheng, W., Kim, J. H., Zhou, B., Caporaso, N. E. 及其他166, Albanes, D., Shin, M. H., Chung, L. P., An, S. J., Wang, P., Zheng, H., Yatabe, Y., Zhang, X. C., Kim, Y. T., Shu, X. O., Kim, Y. C., Bassig, B. A., Chang, J., Man Ho, J. C., Ji, B. T., Kubo, M., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S. I., Nokihara, H., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Yin, Z., Shi, J., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wu, T., Wei, F., Wong, J. Y. Y., Matsuda, F., Su, J., Kim, Y. H., Oh, I. J., Song, F., Lee, V. H. F., Su, W. C., Chen, Y. M., Chang, G. C., Chen, K. Y., Huang, M. S., Yang, P. C., Lin, H. C., Xiang, Y. B., Seow, A., Park, J. Y., Kweon, S. S., Chen, C. J., Li, H., Gao, Y. T., Wu, C., Qian, B., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Wang, W. C., Chung, C. C., Lawrence, C., Burdett, L., Yeager, M., Jacobs, K. B., Hutchinson, A., Berndt, S. I., He, X., Wu, W., Wang, J., Li, Y., Choi, J. E., Park, K. H., Sung, S. W., Liu, L., Kang, C. H., Hu, L., Chen, C. H., Yang, T. Y., Xu, J., Guan, P., Tan, W., Wang, C. L., Loon Sihoe, A. D., Chen, Y., Choi, Y. Y., Hung, J. Y., Kim, J. S., Yoon, H. I., Cai, Q., Lin, C. C., Park, I. K., Xu, P., Dong, J., Kim, C., He, Q., Perng, R. P., Chen, C. Y., Vermeulen, R., Wu, J., Lim, W. Y., Chen, K. C., Chan, J. K. C., Chu, M., Li, Y. J., Li, J., Chen, H., Yu, C. J., Jin, L., Lo, Y. L., Chen, Y. H., Fraumeni, J. F., Liu, J., Yamaji, T., Yang, Y., Hicks, B., Wyatt, K., Li, S. A., Dai, J., Ma, H., Jin, G., Song, B., Wang, Z., Cheng, S., Li, X., Ren, Y., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Zhu, J., Jiang, G., Fei, K., Wu, G., Chien, L. H., Chen, H. L., Su, Y. C., Tsai, F. Y., Chen, Y. S., Yu, J., Stevens, V. L., Laird-Offringa, I. A., Marconett, C. N., Lin, D., Chen, K., Wu, Y. L., Landi, M. T., Shen, H., Rothman, N., Kohno, T., Chanock, S. J. & Lan, Q., 2017, 於 : Human Molecular Genetics. 26, 2, p. 454-465 12 p.

研究成果: Article

22 引文 斯高帕斯(Scopus)
13 引文 斯高帕斯(Scopus)

Cabozantinib in hepatocellular carcinoma: Results of a phase 2 placebo-controlled randomized discontinuation study

Kelley, R. K., Verslype, C., Cohn, A. L., Yang, T. S., Su, W. C., Burris, H., Braiteh, F., Vogelzang, N., Spira, A., Foster, P., Lee, Y. & Van Cutsem, E., 2017, 於 : Annals of Oncology. 28, 3, p. 528-534 7 p.

研究成果: Article

58 引文 斯高帕斯(Scopus)

Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer

Lu, C. S., Shieh, G. S., Wang, C. T., Su, B. H., Su, Y. C., Chen, Y. C., Su, W. C., Wu, P., Yang, W. H., Shiau, A. L. & Wu, C. L., 2017, 於 : Oncotarget. 8, 19, p. 30844-30858 15 p.

研究成果: Article

20 引文 斯高帕斯(Scopus)
4 引文 斯高帕斯(Scopus)
19 引文 斯高帕斯(Scopus)
24 引文 斯高帕斯(Scopus)

EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis

Wang, S. A., Wang, Y. C., Chuang, Y. P., Huang, Y. H., Su, W. C., Chang, W. C. & Hung, J. J., 2017 五月 25, 於 : Oncogene. 36, 21, p. 2930-2945 16 p.

研究成果: Article

7 引文 斯高帕斯(Scopus)

Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer (Oncogene (2016) 35 18 (2357-2369))

Jen, J., Lin, L. L., Lo, F. Y., Chen, H. T., Liao, S. Y., Tang, Y. A., Su, W. C., Salgia, R., Hsu, C. L., Huang, H. C., Juan, H. F. & Wang, Y. C., 2017 八月 1, 於 : Oncogene. 36, 31, 1 p.

研究成果: Comment/debate

開啟存取

Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors

Chang, I. S., Jiang, S. S., Yang, J. C. H., Su, W. C., Chien, L. H., Hsiao, C. F., Lee, J. H., Chen, C. Y., Chen, C. H., Chang, G. C., Wang, Z., Lo, F. Y., Chen, K. Y., Wang, W. C., Chen, Y. M., Huang, M. S., Tsai, Y. H., Su, Y. C., Hsieh, W. S., Shih, W. C. 及其他8, Shieh, S. H., Yang, T. Y., Lan, Q., Rothman, N., Chen, C. J., Chanock, S. J., Yang, P. C. & Hsiung, C. A., 2017 三月 1, 於 : American Journal of Respiratory and Critical Care Medicine. 195, 5, p. 663-673 11 p.

研究成果: Article

7 引文 斯高帕斯(Scopus)